Boothbay Fund Management’s Wave Life Sciences WVE Stock Holding History

Boothbay Fund Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,000	Closed	-$102K	–	2683
2026 Q1	$102K	Buy	+14,000	New	+$182K	﹤0.01%	1875
2025 Q4	–	Sell	-66,700	Closed	-$488K	–	2425
2025 Q3	$488K	Buy	+66,700	New	+$540K	0.01%	1182
2025 Q1	–	Sell	-29,400	Closed	-$364K	–	1829
2024 Q4	$364K	Buy	+29,400	New	+$392K	0.01%	1007
2019 Q4	–	Sell	-924	Closed	-$1.9M	–	1016
2019 Q3	$1.9M	Buy	924 +219	+31%	+$5.02K	0.17%	160
2019 Q2	$1.84M	Buy	+705	New	+$19.8K	0.17%	158

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Boothbay Fund Management's WVE Position: Q2 2026 in Review

Boothbay Fund Management reduced its Wave Life Sciences (WVE) stake by 9.6% in Q2 2026, selling an estimated $102K and leaving 145,000 shares worth $842K. The position accounts for 0.01% of the portfolio, ranked #1211.

Boothbay Fund Management first reported a position in WVE in Q2 2020 and has held it in 17 quarters since. The position peaked at $3.99M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Boothbay Fund Management held 145,000 shares of Wave Life Sciences worth $842K as of Q2 2026.
Boothbay Fund Management sold 15,311 Wave Life Sciences shares in Q2 2026, an estimated $102K.
Wave Life Sciences made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1211 holding.
Boothbay Fund Management first reported a position in Wave Life Sciences in Q2 2020 and has held it in 17 quarters since.
Boothbay Fund Management's Wave Life Sciences position peaked at $3.99M in Q4 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.